Flu Shots Still Available at Concentra Urgent Care Centers
DALLAS, Jan. 15, 2013 /PRNewswire/ — While many public health departments and hospitals are experiencing a surge in demand for flu shots, Concentra, a subsidiary of Humana Inc., is reporting an available quantity of flu vaccines available at its 330 national Concentra Urgent Care medical centers.
The Centers for Disease Control and Prevention (CDC) has stated that 47 states are experiencing widespread flu activity, and an estimated 128 million doses of the flu vaccine have been administered this month, nearly 95 percent of the original doses provided. Concentra Urgent Care has doses available at locations across the nation, with no appointment necessary.
Doctors continue to urge every person to protect against the highly contagious illness by getting an annual flu shot. Experts agree that a flu vaccine is the best defense against contracting the flu virus and has shown to reduce an individual’s chance of getting the flu by up to 90 percent in healthy adults. The CDC confirmed a sharp increase in the number of flu cases, with an estimated 76 percent of cases attributed to the new influenza A (H3N2) virus1. This year’s flu vaccine includes inactive strains of influenza B, and influenza A (H1N1) and (H3N2) viruses.
Influenza, or the flu, is an extremely contagious respiratory infection and often includes symptoms like high fever, cough, and full body aches. Flu symptoms are more severe than those of colds and can cause severe complications, and can cause as many as 49,000 deaths a year. The flu is mostly spread through coughing or sneezing of people with influenza, and touching contaminated surfaces. Adults may be able to transmit the virus to others days before they even know they are sick, as well as while they are sick.
In addition to an available supply of flu shots, Concentra physicians can also provide quality and convenient medical care for patients who may experience flu-like symptoms. Early medical treatment and proper precautions can help to limit the amount of hospital admissions, and reduce any additional costs associated with the flu.
With no appointment necessary, extended evening and weekend hours, and locations throughout the nation, Concentra delivers the care patients need, when they need it most. For a complete list of locations, and more information about the flu, visit www.Concentra.com.
Concentra, a subsidiary of Humana Inc., is a leading health care company focused on improving America’s health, one patient at a time. Through its affiliated clinicians, the company provides occupational medicine, urgent care, physical therapy, and wellness services from more than 330 medical centers in 40 states. In addition to these medical center locations, Concentra serves employers by providing a broad range of health advisory services and operating more than 270 worksite medical facilities. Through this complement of services, Concentra intends to raise the standard of health by putting individuals first, treating them with clinical excellence, and focusing on their ongoing wellness. www.Concentra.com
Humana Inc., headquartered in Louisville, Ky., is a leading health care company that offers a wide range of insurance products and health and wellness services that incorporate an integrated approach to lifelong well-being. By leveraging the strengths of its core businesses, Humana believes it can better explore opportunities for existing and emerging adjacencies in health care that can further enhance wellness opportunities for the millions of people across the nation with whom the company has relationships.
More information regarding Humana is available to investors via the Investor Relations page of the company’s web site at www.humana.com, including copies of:
- Annual reports to stockholders;
- Securities and Exchange Commission filings;
- Most recent investor conference presentations;
- Quarterly earnings news releases;
- Replays of most recent earnings release conference calls;
- Calendar of events (including upcoming earnings conference call dates and times, as well as planned interaction with research analysts and institutional investors);
- Corporate Governance information